Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating suprachoroidal CLS-TA injection for non-infectious uveitis has completed; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panuveitis
• Uveitis
• Uveitis Anterior
• Uveitis Intermediate
• Uveitis Posterior

Drugs mentioned

• CLS-TA (triamcinolone acetonide)

Snippet

Sponsor: Clearside Biomedical, Inc. | Conditions: Uveitis, Uveitis, Posterior | Phase 3 | Status: COMPLETED | Results posted: 2021-06-15